Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

AARP Will Continue Pricing Dialogue With Manufacturers; Website Planned

  • News

Executive Summary

AARP will launch its own pharmaceutical price comparison website in conjunction with the rollout of the Medicare-endorsed discount card program

You may also be interested in...



AARP “Rx Watchdog” Tracking Price Increases Ahead of Medicare Benefit

An upcoming AARP "Rx Watchdog" study will analyze price increases enacted by manufacturers in the first quarter of 2004 heading into the launch of the Medicare drug discount card program

AARP “Rx Watchdog” Tracking Price Increases Ahead of Medicare Benefit

An upcoming AARP "Rx Watchdog" study will analyze price increases enacted by manufacturers in the first quarter of 2004 heading into the launch of the Medicare drug discount card program

Medicare Rx Discount Card Sponsors Expect To Beat CMS’ Savings Estimate

Medicare drug discount card sponsors appear confident that they will be able to provide savings in excess of CMS' projection of 10% to 15%

Table

View full table

Related Content

Pink Sheet
Tags:
Latest Headlines

Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds

Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing

See All
UsernamePublicRestriction

Register

PS043649

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By